Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -579.10% is 106% below its 5-year average of -281.20%, near the low end of its 5-year range (-821.62%–21.86%).
0.70% below its 12-month average of -575.05%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -584.51%.
NET PROFIT MARGIN
-579.10%
NET PROFIT MARGIN AVG TTM
-575.05%
NET PROFIT MARGIN AVG 3Y
-387.39%
NET PROFIT MARGIN AVG 5Y
-281.20%
NET PROFIT MARGIN AVG 10Y
-1319.91%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.70%
CURRENT VS 3Y AVG
-49.49%
CURRENT VS 5Y AVG
-105.94%
CURRENT VS 10Y AVG
+56.13%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-222630.77%
vs the sector median at left
Ocular Therapeutix, Inc.
Market Cap
$1.60B
Net Profit Margin
-579.10%
TTM Avg
-575.05%
3Y Avg
-387.39%
5Y Avg
-281.20%
Market Cap
$1.61B
Net Profit Margin
-1350.73%
TTM Avg
-1059.67%
3Y Avg
-1046.38%
5Y Avg
-742.65%
Market Cap
$1.62B
Net Profit Margin
-24.51%
TTM Avg
-3392.63%
3Y Avg
-1004.26%
5Y Avg
-1004.26%
Market Cap
$1.59B
Net Profit Margin
-140.43%
TTM Avg
-164.31%
3Y Avg
-442.76%
5Y Avg
-354.21%
Market Cap
$1.63B
Net Profit Margin
10.82%
TTM Avg
2.93%
3Y Avg
-1.36%
5Y Avg
-5.99%
Market Cap
$1.62B
Net Profit Margin
-13.50%
TTM Avg
-22.64%
3Y Avg
-31.77%
5Y Avg
-40.07%
Market Cap
$1.56B
Net Profit Margin
-753.60%
TTM Avg
-123.57%
3Y Avg
-563.59%
5Y Avg
-375.72%
Market Cap
$1.54B
Net Profit Margin
80.56%
TTM Avg
35.15%
3Y Avg
48.19%
5Y Avg
54.54%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ocular Therapeutix, Inc. (OCUL) | $1.60B | -579.10% | -575.05% | -387.39% | -281.20% |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 3.13% | 0.65% | -0.01% | 1.74% |
| uniQure N.V. (QURE)vs › | $1.61B | -1350.73% | -1059.67% | -1046.38% | -742.65% |
| Septerna Inc (SEPN)vs › | $1.62B | -24.51% | -3392.63% | -1004.26% | -1004.26% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | -140.43% | -164.31% | -442.76% | -354.21% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 10.82% | 2.93% | -1.36% | -5.99% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.62B | -13.50% | -22.64% | -31.77% | -40.07% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.56B | -753.60% | -123.57% | -563.59% | -375.72% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 80.56% | 35.15% | 48.19% | 54.54% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.53B | -87.60% | -755.85% | -377.93% | -1051.76% |
Operating Margin
-521.0%
Net Profit Margin
-579.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -584.51% |
| 2026-03-31 | -821.62% |
| 2025-12-31 | -487.95% |
| 2025-09-30 | -477.30% |
| 2025-06-30 | -503.86% |
| 2025-03-31 | -598.74% |
| 2024-12-31 | -283.27% |
| 2024-09-30 | -236.58% |
| 2024-06-30 | -266.27% |
| 2024-03-31 | -438.93% |
| 2023-12-31 | -197.42% |
| 2023-09-30 | -3.42% |
| 2023-06-30 | -136.19% |
| 2023-03-31 | -226.69% |
| 2022-12-31 | -110.42% |
| 2022-09-30 | -202.16% |
| 2022-06-30 | -152.99% |
| 2022-03-31 | -95.11% |
| 2021-12-31 | -31.28% |
| 2021-09-30 | 21.86% |
| 2021-06-30 | -72.38% |
| 2021-03-31 | 42.51% |
| 2020-12-31 | -1164.95% |
| 2020-09-30 | -203.27% |
| 2020-06-30 | -2330.66% |
| 2020-03-31 | -824.53% |
| 2019-12-31 | -1153.24% |
| 2019-09-30 | -2265.14% |
| 2019-06-30 | -3762.00% |
| 2019-03-31 | -3480.49% |
| 2018-12-31 | -3452.18% |
| 2018-09-30 | -3014.06% |
| 2018-06-30 | -2130.25% |
| 2018-03-31 | -4048.53% |
| 2017-12-31 | -2690.35% |
| 2017-09-30 | -2976.48% |
| 2017-06-30 | -4268.04% |
| 2017-03-31 | -3373.26% |
| 2016-12-31 | -2509.20% |
| 2016-09-30 | -2011.74% |
| 2016-06-30 | -2595.24% |
| 2016-03-31 | -2366.81% |
| 2015-12-31 | -2439.68% |
| 2015-09-30 | -2686.25% |
| 2015-06-30 | -2180.61% |
| 2015-03-31 | -1778.87% |
| 2014-12-31 | -1575.05% |
| 2014-09-30 | -5100.70% |
| 2014-06-30 | -6589.69% |
| 2014-03-31 | -25955.56% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
